On March 3, 2016, Brian J. Underdown voluntarily resigned from the Board of Argos Therapeutics, Inc., effective upon the initial closing of the financing. There were no disagreements between Mr. Underdown and the company or any officer or director of the company which led to Mr. Underdown's resignation. In conjunction with his resignation, Mr. Underdown also resigned from his role as a member and as chairman of the company's Compensation Committee and as a member of the company's Nominating and Corporate Governance Committee.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -6.22% | +78.50% |
2019 | Argos Therapeutics, Inc. Went Out of Business | CI |
2019 | First Amended Liquidation Plan Approved for Argos Therapeutics, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
+78.50% | 567K | |
-2.01% | 90.28B | |
-0.66% | 39.5B | |
-15.83% | 31.71B | |
+62.42% | 26.41B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-10.32% | 11.8B | |
-45.77% | 10.95B | |
+3.45% | 8.85B |
- Stock Market
- Equities
- ARGSQ Stock
- News Argos Therapeutics, Inc.
- Brian J. Underdown Resigns from the Board, Member and as Chairman of Compensation Committee and as Member of Nominating and Corporate Governance Committee of Argos Therapeutics, Inc